Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 242 | 3 | 1.2 | 58 | 24.0 | 39 | 16.1 | 94 | 38.8 | 48 | 19.8 |
2015-2019 | 250 | 2 | 0.8 | 61 | 24.4 | 42 | 16.8 | 92 | 36.8 | 53 | 21.2 |
2014-2018 | 256 | 1 | 0.4 | 58 | 22.7 | 36 | 14.1 | 104 | 40.6 | 57 | 22.3 |
2013-2017 | 238 | 1 | 0.4 | 47 | 19.7 | 36 | 15.1 | 99 | 41.6 | 55 | 23.1 |
2012-2016 | 235 | 1 | 0.4 | 48 | 20.4 | 39 | 16.6 | 104 | 44.3 | 43 | 18.3 |
2011-2015 | 231 | - | - | 45 | 19.5 | 46 | 19.9 | 103 | 44.6 | 37 | 16.0 |
2010-2014 | 222 | 1 | 0.5 | 48 | 21.6 | 49 | 22.1 | 92 | 41.4 | 32 | 14.4 |
2009-2013 | 208 | 1 | 0.5 | 44 | 21.2 | 51 | 24.5 | 83 | 39.9 | 29 | 13.9 |
2008-2012 | 216 | 1 | 0.5 | 41 | 19.0 | 50 | 23.1 | 93 | 43.1 | 31 | 14.4 |
2007-2011 | 214 | 1 | 0.5 | 40 | 18.7 | 48 | 22.4 | 92 | 43.0 | 33 | 15.4 |
2006-2010 | 196 | 1 | 0.5 | 42 | 21.4 | 41 | 20.9 | 80 | 40.8 | 32 | 16.3 |
2005-2009 | 190 | - | - | 37 | 19.5 | 38 | 20.0 | 79 | 41.6 | 36 | 18.9 |
2004-2008 | 171 | - | - | 38 | 22.2 | 34 | 19.9 | 68 | 39.8 | 31 | 18.1 |
2003-2007 | 158 | - | - | 39 | 24.7 | 34 | 21.5 | 51 | 32.3 | 34 | 21.5 |
2002-2006 | 158 | - | - | 39 | 24.7 | 32 | 20.3 | 48 | 30.4 | 39 | 24.7 |
2001-2005 | 169 | - | - | 39 | 23.1 | 42 | 24.9 | 50 | 29.6 | 38 | 22.5 |
2000-2004 | 162 | - | - | 36 | 22.2 | 37 | 22.8 | 46 | 28.4 | 43 | 26.5 |
1999-2003 | 168 | - | - | 35 | 20.8 | 38 | 22.6 | 46 | 27.4 | 49 | 29.2 |
1998-2002 | 164 | - | - | 38 | 23.2 | 39 | 23.8 | 44 | 26.8 | 43 | 26.2 |
1997-2001 | 157 | - | - | 33 | 21.0 | 43 | 27.4 | 42 | 26.8 | 39 | 24.8 |
1996-2000 | 158 | - | - | 35 | 22.2 | 37 | 23.4 | 42 | 26.6 | 44 | 27.8 |
1995-1999 | 153 | - | - | 34 | 22.2 | 34 | 22.2 | 42 | 27.5 | 43 | 28.1 |
1994-1998 | 150 | - | - | 34 | 22.7 | 31 | 20.7 | 38 | 25.3 | 47 | 31.3 |
1993-1997 | 151 | - | - | 32 | 21.2 | 26 | 17.2 | 44 | 29.1 | 49 | 32.5 |
1992-1996 | 156 | - | - | 34 | 21.8 | 25 | 16.0 | 46 | 29.5 | 51 | 32.7 |
1991-1995 | 145 | - | - | 27 | 18.6 | 22 | 15.2 | 48 | 33.1 | 48 | 33.1 |
1990-1994 | 152 | - | - | 31 | 20.4 | 24 | 15.8 | 52 | 34.2 | 45 | 29.6 |
1989-1993 | 141 | - | - | 28 | 19.9 | 23 | 16.3 | 49 | 34.8 | 41 | 29.1 |
1988-1992 | 133 | - | - | 28 | 21.1 | 23 | 17.3 | 46 | 34.6 | 36 | 27.1 |
1987-1991 | 121 | - | - | 27 | 22.3 | 15 | 12.4 | 41 | 33.9 | 38 | 31.4 |
1986-1990 | 114 | - | - | 27 | 23.7 | 16 | 14.0 | 36 | 31.6 | 35 | 30.7 |
1985-1989 | 102 | - | - | 23 | 22.5 | 18 | 17.6 | 33 | 32.4 | 28 | 27.5 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |